Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

2 structures for P16118

Entry ID Method Resolution Chain Position Source
1K6M X-ray 240 A A/B 40-471 PDB
AF-P16118-F1 Predicted AlphaFoldDB

306 variants for P16118

Variant ID(s) Position Change Description Diseaes Association Provenance
CA10427923
rs775994502
4 E>* No ClinGen
ExAC
CA10427921
rs746356303
5 M>I No ClinGen
ExAC
CA328959970
rs772606041
5 M>L No ClinGen
ExAC
TOPMed
gnomAD
rs772606041
CA10427922
5 M>V No ClinGen
ExAC
TOPMed
gnomAD
CA413278348
rs1487069759
9 T>I No ClinGen
gnomAD
rs1260615825
CA413278314
11 T>I No ClinGen
gnomAD
rs1245610978
CA413278242
16 I>F No ClinGen
TOPMed
TCGA novel 19 P>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA413278138
rs755610050
22 S>R No ClinGen
ExAC
gnomAD
CA10427918
rs372615143
23 G>S Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
CA413278128
rs1318687861
24 S>R No ClinGen
gnomAD
rs1280239027
CA413278119
24 S>T No ClinGen
gnomAD
CA413278097
rs1326010893
25 S>N No ClinGen
gnomAD
rs754571347
CA10427916
27 L>P No ClinGen
ExAC
gnomAD
rs780838121
CA10427917
27 L>V No ClinGen
ExAC
gnomAD
CA10427915
rs751277259
28 Q>L No ClinGen
ExAC
gnomAD
COSM1220240
rs149382881
CA10427913
29 R>Q large_intestine [Cosmic] No ClinGen
cosmic curated
ESP
ExAC
TOPMed
gnomAD
rs368904040
CA10427914
29 R>W Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
TCGA novel 30 R>K Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA413299336
rs1447988166
34 S>T No ClinGen
gnomAD
rs972998087
CA328959304
35 I>T No ClinGen
Ensembl
rs1569546988
CA413299320
36 P>L Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
Ensembl
NCI-TCGA
TCGA novel 39 T>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs138841059
CA10427906
40 N>S No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs150213595
CA10427905
COSM291415
41 S>F Variant assessed as Somatic; 6.255e-05 impact. large_intestine [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
rs772516242
CA10427904
42 P>R No ClinGen
ExAC
TOPMed
gnomAD
rs983725621
CA328959279
43 T>A No ClinGen
Ensembl
TCGA novel 43 T>Q Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs746266406
CA328959276
44 M>L No ClinGen
ExAC
gnomAD
rs746266406
CA10427903
44 M>V No ClinGen
ExAC
gnomAD
rs774931167
CA10427902
47 M>V No ClinGen
ExAC
TOPMed
gnomAD
CA413299238
rs771353686
49 G>A No ClinGen
ExAC
gnomAD
CA10427901
rs771353686
49 G>D No ClinGen
ExAC
gnomAD
CA413299219
rs1440115728
52 A>G No ClinGen
gnomAD
CA328959247
rs867454608
53 R>* No ClinGen
gnomAD
CA413299216
rs1174842375
53 R>Q Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
gnomAD
TCGA novel 56 T>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA413299193
rs1437166764
57 Y>N No ClinGen
gnomAD
rs1279508649
CA413299168
60 T>K No ClinGen
gnomAD
rs754553897
CA10427898
61 K>N No ClinGen
ExAC
gnomAD
CA413299147
rs1343068110
63 T>I No ClinGen
gnomAD
rs372795411
CA328959216
COSM1468742
64 R>* large_intestine Variant assessed as Somatic; impact. [Cosmic, NCI-TCGA] No ClinGen
cosmic curated
ESP
NCI-TCGA
TOPMed
CA413299109
rs1241263594
CA413299111
69 I>L No ClinGen
gnomAD
TCGA novel 69 I>M Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1569546981
CA413299106
69 I>R No ClinGen
Ensembl
CA413299085
rs1307664308
73 T>A Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
gnomAD
rs758125962
CA10427895
74 K>N No ClinGen
ExAC
gnomAD
rs1317889333
CA413299055
75 V>A No ClinGen
TOPMed
rs1334646629
CA413299072
75 V>L No ClinGen
gnomAD
TCGA novel 77 N>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1008831680
CA328957693
78 L>I No ClinGen
gnomAD
rs1362208113
CA413299020
80 Q>R Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA413299012
rs1218319769
81 Y>C Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
CA328957687
rs892692259
82 R>* No ClinGen
Ensembl
rs1315893271
CA413299007
82 R>Q Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
gnomAD
CA10427873
rs147665375
83 R>* Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ESP
ExAC
NCI-TCGA
gnomAD
rs1464583656
CA413299003
83 R>Q Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
CA10427872
rs147013214
84 E>D No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs1414373968
CA413299000
84 E>K No ClinGen
gnomAD
rs753670363
CA10427870
85 A>T No ClinGen
ExAC
TOPMed
gnomAD
rs777798063
CA10427869
86 V>M No ClinGen
ExAC
gnomAD
rs756195368
CA10427868
88 Y>C No ClinGen
ExAC
gnomAD
rs1240581187
CA413298955
90 N>I No ClinGen
gnomAD
rs141391352
CA10427867
91 Y>C No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA413298932
COSM191907
rs1292621025
93 F>L large_intestine Variant assessed as Somatic; impact. [Cosmic, NCI-TCGA] No ClinGen
cosmic curated
NCI-TCGA
TOPMed
gnomAD
rs767762591
CA10427866
93 F>Y No ClinGen
ExAC
TOPMed
gnomAD
rs751844731
CA10427864
96 P>A No ClinGen
ExAC
gnomAD
CA413298899
rs1156585179
98 N>D No ClinGen
TOPMed
CA10427862
rs147830659
98 N>I No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA10427861
rs773547844
99 M>T No ClinGen
ExAC
gnomAD
rs1461592038
CA413298892
99 M>V No ClinGen
TOPMed
rs770352304
CA10427860
105 R>G No ClinGen
ExAC
TOPMed
gnomAD
rs1248887214 106 K>= Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No NCI-TCGA
rs1212357184
CA413298818
107 Q>H No ClinGen
TOPMed
gnomAD
rs1468387179
CA413298816
108 C>R No ClinGen
gnomAD
CA413298807
rs1198684471
109 A>T No ClinGen
TOPMed
gnomAD
rs1308796224
CA413298793
111 A>V No ClinGen
TOPMed
gnomAD
CA413298769
rs1262220774
115 D>G No ClinGen
TOPMed
rs1213691478
CA413298765
116 V>I No ClinGen
gnomAD
CA10427849
rs148659686
118 N>S No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA413298740
rs1276333617
119 Y>C No ClinGen
TOPMed
gnomAD
CA413298739
rs1276333617
119 Y>F No ClinGen
TOPMed
gnomAD
rs1438446795
CA413298720
122 H>Y No ClinGen
gnomAD
CA413298706
rs1273340193
124 E>K No ClinGen
TOPMed
CA10427848
rs781388819
127 V>A No ClinGen
ExAC
gnomAD
rs201183926 128 A>= Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No NCI-TCGA
COSM269873
CA10427847
rs202099559
128 A>V large_intestine [Cosmic] No ClinGen
cosmic curated
ESP
ExAC
TOPMed
gnomAD
TCGA novel 132 A>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1569546931
CA413298610
136 T>I No ClinGen
Ensembl
rs773053257
CA10427833
136 T>S No ClinGen
ExAC
gnomAD
CA10427832
rs769750855
137 R>G No ClinGen
ExAC
gnomAD
CA10427830
COSM1123577
rs781298920
139 R>* Variant assessed as Somatic; 0.0 impact. endometrium [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
TOPMed
gnomAD
rs1408406355
CA413298594
139 R>Q No ClinGen
TOPMed
COSM3694663
rs1387380681
CA413298590
140 R>Q large_intestine [Cosmic] No ClinGen
cosmic curated
TOPMed
rs747113593
CA10427828
140 R>W Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
rs780058993
CA10427827
143 I>L No ClinGen
ExAC
gnomAD
CA10427823
rs757641577
148 K>E No ClinGen
ExAC
gnomAD
rs1434452904
CA413298538
148 K>R No ClinGen
gnomAD
rs764589093
COSM1468741
CA10427821
149 E>* Variant assessed as Somatic; 0.0 impact. large_intestine [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
TOPMed
gnomAD
CA10427819
rs139060082
150 H>R No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA10427820
rs758914513
150 H>Y No ClinGen
ExAC
gnomAD
rs780551387
CA10427818
152 Y>C No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 153 K>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA413298473
rs1300364885
155 F>L No ClinGen
gnomAD
rs1316984028
CA413298469
156 F>V No ClinGen
TOPMed
gnomAD
rs778168151
CA10427804
159 S>F No ClinGen
ExAC
gnomAD
rs920287775
CA328955964
159 S>T No ClinGen
gnomAD
CA413298443
rs1466877967
160 I>V No ClinGen
TOPMed
rs756639395
CA10427803
161 C>Y No ClinGen
ExAC
gnomAD
CA10427802
rs753182523
163 D>N No ClinGen
ExAC
gnomAD
CA10427801
rs765889495
167 I>V No ClinGen
ExAC
gnomAD
TCGA novel 168 A>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA10427800
rs762389876
172 R>G No ClinGen
ExAC
TOPMed
gnomAD
CA10427799
rs750054026
172 R>K No ClinGen
ExAC
TOPMed
gnomAD
rs1395513929
CA413298342
173 Q>K No ClinGen
gnomAD
CA328954950
rs1026355703
174 V>M No ClinGen
TOPMed
TCGA novel 176 L>R Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1167114695
CA413298312
177 G>D No ClinGen
gnomAD
CA10427784
rs372826497
178 S>G No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1602194428
CA413298281
182 I>V No ClinGen
Ensembl
TCGA novel 183 D>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 183 D>Y Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs781578516
CA10427783
185 D>Y No ClinGen
ExAC
gnomAD
CA10427781
rs749962265
186 R>Q No ClinGen
ExAC
TOPMed
gnomAD
CA10427782
rs757855528
186 R>W No ClinGen
ExAC
TOPMed
gnomAD
CA10427780
rs764894133
187 E>G No ClinGen
ExAC
gnomAD
CA10427779
CA10427778
rs146170729
188 K>N No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs763904042
CA10427777
189 V>A No ClinGen
ExAC
gnomAD
CA413298221
rs1569546880
191 E>V No ClinGen
Ensembl
rs1318752953
CA413298198
194 L>P No ClinGen
gnomAD
COSM257711
CA413298185
rs1253259797
196 R>I Variant assessed as Somatic; 0.0 impact. large_intestine [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
NCI-TCGA
gnomAD
rs775433301
CA10427775
197 I>T No ClinGen
ExAC
TOPMed
gnomAD
rs780499830
CA328954880
200 Y>C No ClinGen
TOPMed
gnomAD
CA413298153
rs1302348868
201 E>K Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
gnomAD
CA413298136
rs1449750008
203 N>S No ClinGen
TOPMed
CA328954875
rs1016412044
204 Y>D No ClinGen
Ensembl
rs1470495289
CA413298122
205 Q>* No ClinGen
TOPMed
gnomAD
rs1369378953
CA413298120
205 Q>R No ClinGen
TOPMed
gnomAD
rs774408939
CA10427772
206 P>H No ClinGen
ExAC
gnomAD
rs759529269
CA10427773
206 P>S No ClinGen
ExAC
TOPMed
gnomAD
rs1460097374
CA413298101
208 D>G No ClinGen
TOPMed
gnomAD
CA413298105
rs1169267973
208 D>H No ClinGen
gnomAD
TCGA novel 210 E>D Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA413298030
rs1172922955
216 S>C No ClinGen
TOPMed
gnomAD
CA413298010
rs1470438805
219 K>R No ClinGen
gnomAD
CA10427756
rs774321022
222 D>N No ClinGen
ExAC
TOPMed
gnomAD
CA10427755
rs774321022
222 D>Y No ClinGen
ExAC
TOPMed
gnomAD
CA10427753
rs763051175
223 V>M No ClinGen
ExAC
TOPMed
gnomAD
COSM1123569
CA10427752
rs769684822
226 R>C Variant assessed as Somatic; 0.0 impact. oesophagus endometrium [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
TOPMed
gnomAD
rs769919634
CA10427751
226 R>H Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
CA413297951
rs1241328281
228 M>I No ClinGen
gnomAD
CA10427750
rs748456222
228 M>K No ClinGen
ExAC
gnomAD
rs1484895180
CA413297954
228 M>L No ClinGen
gnomAD
rs1214614398
CA413297935
230 N>K No ClinGen
TOPMed
CA413297938
rs1353416853
230 N>S No ClinGen
gnomAD
CA328950535
rs369550583
231 R>* No ClinGen
ESP
TOPMed
gnomAD
CA413297931
rs1236223334
231 R>L No ClinGen
TOPMed
gnomAD
CA413297933
rs1236223334
231 R>Q No ClinGen
TOPMed
gnomAD
CA10427749
rs199630999
232 V>L No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 233 Q>R Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA328950531
rs997697891
234 D>G No ClinGen
TOPMed
gnomAD
CA413297913
rs997697891
234 D>V No ClinGen
TOPMed
gnomAD
rs1313106902
CA413297917
234 D>Y No ClinGen
gnomAD
TCGA novel 236 I>M Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA413297897
rs1373255410
236 I>T No ClinGen
gnomAD
CA10427748
rs769195741
239 R>C No ClinGen
ExAC
gnomAD
rs780740994
CA10427746
239 R>H No ClinGen
ExAC
TOPMed
gnomAD
rs780740994
CA10427747
239 R>L No ClinGen
ExAC
TOPMed
gnomAD
rs1410012097
CA413297871
240 T>I No ClinGen
gnomAD
CA413297851
rs1381855192
243 Y>C No ClinGen
TOPMed
CA10427744
rs143062179
245 M>I No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1469666598
CA413297815
248 H>R No ClinGen
gnomAD
CA10427743
rs56031427
249 V>I No ClinGen
ExAC
gnomAD
rs777399343
CA10427742
252 R>C No ClinGen
ExAC
TOPMed
gnomAD
CA10427741
rs761648445
252 R>H No ClinGen
ExAC
TOPMed
gnomAD
CA413297788
rs1449144916
253 S>A No ClinGen
gnomAD
rs146369182
CA10427740
254 I>T No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1401160015
CA413297768
256 L>F No ClinGen
gnomAD
rs1401160015
CA413297770
256 L>I No ClinGen
gnomAD
rs1349313159
CA413297757
257 C>W No ClinGen
gnomAD
CA413297755
rs1379500249
258 R>* No ClinGen
TOPMed
CA10427739
rs767193275
258 R>Q No ClinGen
ExAC
TOPMed
gnomAD
CA413297744
rs1234598701
260 G>S No ClinGen
gnomAD
rs751457409
CA10427737
261 E>* No ClinGen
ExAC
TOPMed
gnomAD
CA413297736
rs1287698653
261 E>G No ClinGen
TOPMed
rs751457409
CA413297738
261 E>K No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 267 R>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1346791348
CA413297681
268 G>V No ClinGen
gnomAD
rs762959184
CA10427735
269 R>C Variant assessed as Somatic; 6.672e-05 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
rs376959812
CA10427734
269 R>H No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA413297675
rs1459960270
270 I>V No ClinGen
gnomAD
CA10427732
rs143311323
271 G>R No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA413297644
rs1476590540
275 G>S No ClinGen
gnomAD
COSM1123567
CA10427731
rs201795827
279 R>C endometrium [Cosmic] No ClinGen
cosmic curated
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA10427729
rs747386480
279 R>H No ClinGen
ExAC
TOPMed
gnomAD
CA10427730
rs747386480
279 R>L No ClinGen
ExAC
TOPMed
gnomAD
CA413297620
rs201795827
279 R>S No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA10427727
rs149578224
280 G>C No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA10427726
rs149578224
280 G>S No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA413297614
rs1319186398
280 G>V No ClinGen
TOPMed
gnomAD
rs958005204
CA328949116
283 Y>* No ClinGen
TOPMed
rs1602185887
CA413297541
289 N>S No ClinGen
Ensembl
TCGA novel 295 G>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1019880075
CA328949113
295 G>V No ClinGen
Ensembl
CA10427714
rs750412089
297 S>G No ClinGen
ExAC
gnomAD
rs1349023697
CA413297444
301 V>M No ClinGen
gnomAD
rs183245021
CA10427712
302 W>R No ClinGen
1000Genomes
ExAC
gnomAD
rs1352931712
CA413297408
303 T>A Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
rs1352931712
CA413297410
303 T>P No ClinGen
gnomAD
rs1042227
CA328949081
305 H>R No ClinGen
Ensembl
CA10427711
rs753943938
306 M>L No ClinGen
ExAC
gnomAD
rs1397349463
CA413297292
311 Q>E No ClinGen
gnomAD
CA10427709
rs780371848
311 Q>P No ClinGen
ExAC
TOPMed
gnomAD
CA10427710
rs780371848
311 Q>R No ClinGen
ExAC
TOPMed
gnomAD
rs1454178195
CA413297258
313 A>P No ClinGen
gnomAD
rs775994554
CA10427708
314 E>A No ClinGen
ExAC
gnomAD
rs772606130
CA10427706
320 Y>C No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 320 Y>H Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA413297191
rs1333834571
321 E>D No ClinGen
TOPMed
rs759937599
CA10427705
326 L>Q No ClinGen
ExAC
TOPMed
gnomAD
rs1569546754
CA413297105
327 N>S No ClinGen
Ensembl
rs774942418
CA10427704
327 N>Y No ClinGen
ExAC
gnomAD
CA328948996
COSM326124
rs956391574
329 I>F lung [Cosmic] No ClinGen
cosmic curated
TOPMed
rs1282123545
CA413297067
329 I>T No ClinGen
gnomAD
rs147029348
CA10427702
331 A>V Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
CA10427688
rs753018383
333 V>F No ClinGen
ExAC
CA10427686
rs759975430
COSM757987
334 C>F lung Variant assessed as Somatic; 0.0 impact. [Cosmic, NCI-TCGA] No ClinGen
cosmic curated
ExAC
NCI-TCGA
gnomAD
rs967146302
CA328947369
337 M>I No ClinGen
Ensembl
CA10427683
rs763425189
347 P>L No ClinGen
ExAC
gnomAD
CA10427684
COSM1468738
rs771482577
347 P>S large_intestine Variant assessed as Somatic; impact. [Cosmic, NCI-TCGA] No ClinGen
cosmic curated
ExAC
NCI-TCGA
gnomAD
rs374547963
CA10427682
350 F>Y No ClinGen
ESP
ExAC
gnomAD
TCGA novel 351 A>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1357568698
CA413296238
352 L>P No ClinGen
gnomAD
rs200225578
CA328947350
352 L>V No ClinGen
Ensembl
CA10427681
rs368782445
353 R>* Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
COSM1123565
CA10427680
rs759599398
353 R>Q Variant assessed as Somatic; 0.0 impact. endometrium [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
1000Genomes
ExAC
NCI-TCGA
gnomAD
CA413296226
rs1569546712
354 D>E No ClinGen
Ensembl
rs1409317803
CA413296223
355 Q>* No ClinGen
TOPMed
rs775158265
CA10427679
357 K>E No ClinGen
ExAC
gnomAD
rs201921095
CA328947324
358 Y>H No ClinGen
Ensembl
COSM273100
CA10427678
rs771700798
359 R>C Variant assessed as Somatic; 0.0 impact. large_intestine [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
TOPMed
gnomAD
rs370865554
CA10427677
359 R>H No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1392212560
CA413296179
361 R>H No ClinGen
TOPMed
CA10427676
rs774242075
363 P>S No ClinGen
1000Genomes
ExAC
gnomAD
CA413296156
rs1157720743
365 G>R No ClinGen
gnomAD
rs745575470
CA10427658
367 S>C No ClinGen
ExAC
TOPMed
gnomAD
rs774164699
CA10427657
368 Y>C No ClinGen
ExAC
gnomAD
CA413294889
rs1373297950
371 L>M No ClinGen
gnomAD
rs1001255153
CA328942025
371 L>P No ClinGen
TOPMed
rs981461647
CA328942019
372 V>L No ClinGen
Ensembl
rs899872635
CA328942013
373 Q>* No ClinGen
TOPMed
CA10427656
rs368958510
374 R>H Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
rs1222639575
CA413294873
374 R>S No ClinGen
TOPMed
CA10427654
rs777882733
375 L>Q No ClinGen
ExAC
rs1247303595
CA413294854
377 P>A No ClinGen
gnomAD
rs776503507
CA10427653
381 E>V No ClinGen
1000Genomes
ExAC
gnomAD
CA10427652
rs377564103
382 L>V No ClinGen
ESP
ExAC
gnomAD
rs373419320
CA10427649
384 R>* No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs766741308
CA10427648
385 Q>E No ClinGen
ExAC
gnomAD
rs752742853
CA328941956
385 Q>P No ClinGen
Ensembl
CA413294795
rs1253332156
386 E>G No ClinGen
gnomAD
rs758781475
CA10427647
387 N>D No ClinGen
ExAC
gnomAD
CA10427645
rs762369271
393 H>Q No ClinGen
ExAC
gnomAD
CA413294728
rs1231533779
393 H>Y No ClinGen
TOPMed
gnomAD
rs200786691
CA10427643
394 Q>E No ClinGen
ExAC
TOPMed
gnomAD
rs766976938
CA10427642
397 M>V No ClinGen
ExAC
gnomAD
CA10427640
rs150980930
398 R>Q No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA10427641
rs140853589
398 R>W Variant assessed as Somatic; 0.0007532 impact. [NCI-TCGA] No ClinGen
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
rs1396715748
CA413294579
402 A>D No ClinGen
TOPMed
gnomAD
TCGA novel 402 A>G Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs865998447
CA328941919
402 A>S No ClinGen
Ensembl
rs1396715748
CA413294575
402 A>V No ClinGen
TOPMed
gnomAD
CA10427639
rs142567584
403 Y>* No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA10427638
rs148416501
405 L>P No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs773225724
CA10427637
406 D>N No ClinGen
ExAC
gnomAD
CA413294494
rs1174038442
407 K>N No ClinGen
gnomAD
CA413294489
rs1455491011
408 S>G No ClinGen
gnomAD
rs146672025
CA10427636
408 S>N No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1369577573
CA413294251
411 E>K No ClinGen
gnomAD
rs1313213154
CA413294229
412 L>F No ClinGen
gnomAD
rs866879766
CA328940772
413 P>S No ClinGen
Ensembl
rs1399942818
CA413294134
420 H>P No ClinGen
TOPMed
gnomAD
CA328940743
rs1009563843
429 A>T No ClinGen
gnomAD
rs750333012
CA10427622
430 Y>C No ClinGen
1000Genomes
ExAC
gnomAD
rs750333012
CA10427623
430 Y>F No ClinGen
1000Genomes
ExAC
gnomAD
TCGA novel 430 Y>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA413293301
rs1159470533
431 G>D No ClinGen
TOPMed
rs1423228745
CA413293282
433 K>E No ClinGen
TOPMed
CA328940386
rs774997599
434 V>A No ClinGen
1000Genomes
TCGA novel 435 E>K Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs866461519
CA328940363
442 E>K No ClinGen
Ensembl
CA10427607
rs201730176
444 V>M Variant assessed as Somatic; 6.252e-05 impact. [NCI-TCGA] No ClinGen
1000Genomes
ExAC
NCI-TCGA
TOPMed
gnomAD
rs751020074
CA10427606
448 R>Q No ClinGen
ExAC
TOPMed
gnomAD
rs762376817
CA328940359
448 R>W No ClinGen
Ensembl
rs774588232
CA10427592
455 D>G No ClinGen
ExAC
TOPMed
gnomAD
rs746042228
CA10427593
455 D>H No ClinGen
ExAC
gnomAD
CA10427591
rs771262197
456 I>V No ClinGen
ExAC
gnomAD
CA328940052
COSM1468737
rs934661751
458 R>Q Variant assessed as Somatic; 0.0 impact. large_intestine [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
NCI-TCGA
TOPMed
gnomAD
rs1225601455
CA413292766
458 R>W No ClinGen
TOPMed
COSM3800681
CA413292755
rs1288738705
459 E>K Variant assessed as Somatic; 0.0 impact. urinary_tract [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
NCI-TCGA
gnomAD
CA413292740
rs1214907005
460 P>H No ClinGen
gnomAD
TCGA novel 461 E>D Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA413292655
rs1277580022
467 V>I No ClinGen
TOPMed
gnomAD
CA413292615
rs1227495277
469 A>G No ClinGen
gnomAD
rs749625958
CA10427590
469 A>T No ClinGen
ExAC
gnomAD
TCGA novel 472 Y>= Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA

No associated diseases with P16118

No regional properties for P16118

Type Name Position InterPro Accession
No domain, repeats, and functional sites for P16118

Functions

Description
EC Number 2.7.1.105 Phosphotransferases with an alcohol group as acceptor
Subcellular Localization
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

2 GO annotations of cellular component

Name Definition
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase complex A homodimeric, bifunctional enzyme complex which catalyzes the synthesis and degradation of fructose 2,6-bisphosphate, and is required for both glycolysis and gluconeogenesis.
cytosol The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.

6 GO annotations of molecular function

Name Definition
6-phosphofructo-2-kinase activity Catalysis of the reaction: beta-D-fructose 6-phosphate + ATP = beta-D-fructose 2,6-bisphosphate + ADP + 2 H(+).
ATP binding Binding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.
fructose-2,6-bisphosphate 2-phosphatase activity Catalysis of the reaction: D-fructose 2,6-bisphosphate + H2O = D-fructose-6-phosphate + phosphate.
fructose-6-phosphate binding Binding to fructose 6-phosphate.
identical protein binding Binding to an identical protein or proteins.
kinase binding Binding to a kinase, any enzyme that catalyzes the transfer of a phosphate group.

11 GO annotations of biological process

Name Definition
animal organ regeneration The regrowth of a lost or destroyed animal organ.
fructose 2,6-bisphosphate metabolic process The chemical reactions and pathways involving fructose 2,6-bisphosphate. The D enantiomer is an important regulator of the glycolytic and gluconeogenic pathways. It inhibits fructose 1,6-bisphosphatase and activates phosphofructokinase.
fructose metabolic process The chemical reactions and pathways involving fructose, the ketohexose arabino-2-hexulose. Fructose exists in a open chain form or as a ring compound. D-fructose is the sweetest of the sugars and is found free in a large number of fruits and honey.
gluconeogenesis The formation of glucose from noncarbohydrate precursors, such as pyruvate, amino acids and glycerol.
glycolytic process The chemical reactions and pathways resulting in the breakdown of a carbohydrate into pyruvate, with the concomitant production of a small amount of ATP and the reduction of NAD(P) to NAD(P)H. Glycolysis begins with the metabolism of a carbohydrate to generate products that can enter the pathway and ends with the production of pyruvate. Pyruvate may be converted to acetyl-coenzyme A, ethanol, lactate, or other small molecules.
positive regulation of glucokinase activity Any process that activates or increases the frequency, rate or extent of glucokinase activity, the catalysis of the transfer of a phosphate group, usually from ATP, to a glucose molecule.
response to cAMP Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cAMP (cyclic AMP, adenosine 3',5'-cyclophosphate) stimulus.
response to glucagon Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a glucagon stimulus.
response to glucocorticoid Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a glucocorticoid stimulus. Glucocorticoids are hormonal C21 corticosteroids synthesized from cholesterol with the ability to bind with the cortisol receptor and trigger similar effects. Glucocorticoids act primarily on carbohydrate and protein metabolism, and have anti-inflammatory effects.
response to insulin Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an insulin stimulus. Insulin is a polypeptide hormone produced by the islets of Langerhans of the pancreas in mammals, and by the homologous organs of other organisms.
response to starvation Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a starvation stimulus, deprivation of nourishment.

13 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
P32604 FBP26 Fructose-2,6-bisphosphatase Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast) PR
P26285 PFKFB2 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2 Bos taurus (Bovine) PR
P49872 PFKFB1 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 1 Bos taurus (Bovine) PR
O60825 PFKFB2 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2 Homo sapiens (Human) PR
Q16877 PFKFB4 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4 Homo sapiens (Human) PR
Q16875 PFKFB3 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 Homo sapiens (Human) PR
P70265 Pfkfb2 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2 Mus musculus (Mouse) PR
Q6DTY7 Pfkfb4 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4 Mus musculus (Mouse) PR
P70266 Pfkfb1 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 1 Mus musculus (Mouse) PR
O35552 Pfkfb3 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 Rattus norvegicus (Rat) PR
P25114 Pfkfb4 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4 Rattus norvegicus (Rat) PR
Q9JJH5 Pfkfb2 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2 Rattus norvegicus (Rat) PR
P07953 Pfkfb1 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 1 Rattus norvegicus (Rat) PR
10 20 30 40 50 60
MSPEMGELTQ TRLQKIWIPH SSGSSRLQRR RGSSIPQFTN SPTMVIMVGL PARGKTYIST
70 80 90 100 110 120
KLTRYLNWIG TPTKVFNLGQ YRREAVSYKN YEFFLPDNME ALQIRKQCAL AALKDVHNYL
130 140 150 160 170 180
SHEEGHVAVF DATNTTRERR SLILQFAKEH GYKVFFIESI CNDPGIIAEN IRQVKLGSPD
190 200 210 220 230 240
YIDCDREKVL EDFLKRIECY EVNYQPLDEE LDSHLSYIKI FDVGTRYMVN RVQDHIQSRT
250 260 270 280 290 300
VYYLMNIHVT PRSIYLCRHG ESELNIRGRI GGDSGLSVRG KQYAYALANF IQSQGISSLK
310 320 330 340 350 360
VWTSHMKRTI QTAEALGVPY EQWKALNEID AGVCEEMTYE EIQEHYPEEF ALRDQDKYRY
370 380 390 400 410 420
RYPKGESYED LVQRLEPVIM ELERQENVLV ICHQAVMRCL LAYFLDKSSD ELPYLKCPLH
430 440 450 460 470
TVLKLTPVAY GCKVESIYLN VEAVNTHREK PENVDITREP EEALDTVPAH Y